Elvitegravir
**Elvitegravir: A Potent Antiretroviral for HIV Treatment**
Elvitegravir is an integrase strand transfer inhibitor (INSTI) used to treat HIV-1 infection. It blocks the integrase enzyme, preventing the virus from integrating its genetic material into host cells and multiplying.
**Key Features:**
* Approved by the FDA in 2012
* Highly effective in suppressing viral replication
* Well-tolerated with a low risk of side effects
* Available as a combination tablet with other antiretrovirals
**Indication:**
Elvitegravir is indicated for adults and adolescents over 12 years of age with HIV-1 infection, in combination with other antiretrovirals.
**Dosage:**
The recommended dosage of elvitegravir is 150 mg once daily.
**Benefits:**
* Potent antiviral activity
* Excellent tolerability
* Reduces viral load to undetectable levels
* Improves immune function
* Prevents disease progression
**Keywords:**
* Elvitegravir
* HIV treatment
* Integrase inhibitor
* Antiretroviral
* HIV-1
Discover Stribild Dosage: Tailored Treatment for HIV-1 Infection
Stribild (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate) is a prescription drug that’s used to treat HIV in certain situations. The drug comes as an oral tablet that you usually take once a day. Stribild is approved for adults and…